{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:16:43Z","timestamp":1791566203753,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tmaid.2024.102697","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:39:50Z","timestamp":1708119590000},"page":"102697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Real-world evidence of rabies post-exposure prophylaxis in Serbia: Nation-wide observational study (2017\u20132019)"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-6606","authenticated-orcid":false,"given":"Pavle","family":"Banovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Mijatovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verica","family":"Simin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Vranje\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Meletis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polychronis","family":"Kostoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasiel","family":"Obregon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cabezas-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2024.102697_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v13091769","article-title":"Renewed public health threat from emerging lyssaviruses","volume":"13","author":"Fooks","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2024.102697_bib2","unstructured":"Resurgence of fox rabies in a formerly freed area in Poland | Rabies - Bulletin - Europe n.d. https:\/\/www.who-rabies-bulletin.org\/news\/resurgence-fox-rabies-formerly-freed-area-poland (accessed December 4, 2022)."},{"key":"10.1016\/j.tmaid.2024.102697_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.31631\/2073-3046-2020-19-5-41-48","article-title":"Current trends in epidemiology of rabies in Belarus","volume":"19","author":"Hanenko","year":"2020","journal-title":"Epidemiology and Vaccinal Prevention"},{"key":"10.1016\/j.tmaid.2024.102697_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/pathogens10060742","article-title":"Current status of rabies and its eradication in eastern and southeastern europe","volume":"10","author":"Lojki\u0107","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.tmaid.2024.102697_bib5","article-title":"Rabies virus spread in central and north-eastern regions of Ukraine","volume":"78","author":"Omelchenko","year":"2022","journal-title":"Med Weter"},{"key":"10.1016\/j.tmaid.2024.102697_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2021.04.010","article-title":"Rabies in Europe: an epidemiological and clinical update","volume":"88","author":"Riccardi","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12917-019-2209-x","article-title":"Detection of rabies antibodies in wild boars in north-east Romania by a rabies ELISA test","volume":"15","author":"Dascalu","year":"2019","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.tmaid.2024.102697_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.15421\/022134","article-title":"Current issues and gaps in the implementation of rabies prevention in Ukraine in recent decades","volume":"12","author":"Makovska","year":"2021","journal-title":"Regulatory Mechanisms in Biosystems"},{"key":"10.1016\/j.tmaid.2024.102697_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2019.00290","article-title":"An analysis of rabies incidence and its geographic spread in the buffer area among orally vaccinated wildlife in Ukraine from 2012 to 2016","volume":"6","author":"Polupan","year":"2019","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.tmaid.2024.102697_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijid.2022.10.046","article-title":"Global burden of rabies in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019","volume":"126","author":"Gan","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102697_bib11","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1017\/S0950268821000601","article-title":"Rabies post-exposure prophylaxis in Germany - what are the challenges?","volume":"149","author":"Meyerhoff","year":"2021","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.tmaid.2024.102697_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001852","article-title":"Risk of potentially rabid animal exposure among foreign travelers in Southeast Asia","volume":"6","author":"Piyaphanee","year":"2012","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2024.102697_bib13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4269\/ajtmh.2010.09-0699","article-title":"Rabies exposure risk among foreign backpackers in Southeast Asia","volume":"82","author":"Piyaphanee","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102697_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"Kessels","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2024.102697_bib15","unstructured":"Rabies vaccines: WHO position paper \u2013 April 2018 n.d. https:\/\/www.who.int\/publications-detail-redirect\/who-wer9316 (accessed December 4, 2022)."},{"key":"10.1016\/j.tmaid.2024.102697_bib16","series-title":"WHO Expert Committee on Rabies [meeting held in Geneva from 24 to 30 September 1991] : eighth report","year":"1992"},{"key":"10.1016\/j.tmaid.2024.102697_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0019-557X.152867","article-title":"Compliance to anti-rabies vaccination in post-exposure prophylaxis","volume":"59","author":"Shankaraiah","year":"2015","journal-title":"Indian J Publ Health"},{"key":"10.1016\/j.tmaid.2024.102697_bib18","series-title":"WHO expert consultation on rabies: second report","year":"2013"},{"key":"10.1016\/j.tmaid.2024.102697_bib19","series-title":"WHO expert consultation on rabies: third report","year":"2018"},{"key":"10.1016\/j.tmaid.2024.102697_bib20","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.tmaid.2024.102697_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/cid\/ciy513","article-title":"Preexposure intradermal rabies vaccination: a noninferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days","volume":"68","author":"Soentjens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102697_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax033","article-title":"Single visit rabies pre-exposure priming induces a robust anamnestic antibody response after simulated post-exposure vaccination: results of a dose-finding study","volume":"24","author":"Jonker","year":"2017","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib23","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1080\/21645515.2021.1883388","article-title":"Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: a non - randomized, comparative controlled study","volume":"17","author":"Haradanahalli","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/cis384","article-title":"Rabies postexposure prophylaxis in routine practice in view of the new centers for disease control and prevention and world health organization recommendations","volume":"55","author":"Uwanyiligira","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102697_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2138049","article-title":"A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency","author":"Zhou","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib26","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/21645515.2021.1880200","article-title":"Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: a post-marketing, parallel control clinical trial","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/21645515.2020.1778408","article-title":"Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial","volume":"17","author":"Shen","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197883","article-title":"Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment","volume":"278","author":"Gholami","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.tmaid.2024.102697_bib29","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen","volume":"24","author":"Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib30","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2013.10.043","article-title":"A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab\u00ae when administered according to a post-exposure regimen in healthy children and adults in China","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/cer-2019-0202","article-title":"Meta-analysis of immunogenicity and safety of human rabies vaccination under Zagreb and Essen regimens","volume":"9","author":"Li","year":"2020","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.tmaid.2024.102697_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","article-title":"Vaccination in the elderly: an immunological perspective","volume":"30","author":"Chen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tmaid.2024.102697_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tmaid.2024.102697_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/picr.PICR_8_19","article-title":"Conducting real-world evidence studies in India","volume":"10","author":"Bhatt","year":"2019","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.tmaid.2024.102697_bib35","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records","volume":"33","author":"Kim","year":"2018","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.tmaid.2024.102697_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"Chodankar","year":"2021","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.tmaid.2024.102697_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102573","article-title":"Rabies post-exposure prophylaxis of international travellers - results from two major German travel clinics","volume":"53","author":"Saffar","year":"2023","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102697_bib38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jtm.12228","article-title":"Rabies vaccine and rabies immunoglobulin in Cambodia: use and obstacles to use","volume":"22","author":"Tarantola","year":"2015","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2310\/7060.2000.00057","article-title":"Neutralizing antibodies to rabies following injection of rabies immune globulin into gluteal fat or deltoid muscle","volume":"7","author":"Chomchay","year":"2000","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib40","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.38.2000158","article-title":"Prevention of human rabies: a challenge for the European union and the European economic area","volume":"25","author":"Gossner","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2024.102697_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2021.677907","article-title":"Vaccines and senior travellers","volume":"2","author":"Ecarnot","year":"2021","journal-title":"Front Aging"},{"key":"10.1016\/j.tmaid.2024.102697_bib42","first-page":"279","article-title":"New immunization schedule with seroconversion testing","volume":"2","author":"Mu\u0161kinja","year":"2010","journal-title":"Med Data Rev"},{"key":"10.1016\/j.tmaid.2024.102697_bib43","first-page":"12","author":"Lon\u010darevi\u0107","year":"2017","journal-title":"Stru\u010dno-metodolo\u0161ko uputstvo za sprovo\u0111enje obavezne i preporu\u010dene imunizacije stanovni\u0161tva za 2017. godinu"},{"key":"10.1016\/j.tmaid.2024.102697_bib44","first-page":"283","article-title":"Validation of the Rapid fluorescent focus inhibition test for rabies antibodies","volume":"2","author":"Stankov","year":"2010","journal-title":"Med Data Rev"},{"key":"10.1016\/j.tmaid.2024.102697_bib45","unstructured":"R: The R Project for Statistical Computing n.d. https:\/\/www.r-project.org\/(accessed July 19, 2023)."},{"key":"10.1016\/j.tmaid.2024.102697_bib46","series-title":"TL (original S->R port and R maintainer, Elizabeth A, Cynthia C. survival: survival Analysis 2023","author":"Therneau","year":"2009"},{"key":"10.1016\/j.tmaid.2024.102697_bib47","series-title":"Coxme: mixed effects Cox models","author":"Therneau","year":"2022"},{"key":"10.1016\/j.tmaid.2024.102697_bib48","series-title":"survminer: drawing Survival Curves using \u201cggplot2\u201d","author":"Kassambara","year":"2021"},{"key":"10.1016\/j.tmaid.2024.102697_bib49","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2018.10.014","article-title":"The WHO position on rabies immunization \u2013 2018 updates","volume":"37","author":"O'Brien","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4161\/21645515.2014.994460","article-title":"Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib51","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0264-410X(94)90310-7","article-title":"Immune response of the elderly to rabies vaccines","volume":"12","author":"Mastroeni","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa006","article-title":"Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster","volume":"27","author":"Furuya-Kanamori","year":"2020","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250164","article-title":"Autoantibodies targeting type I interferons: prevalence, mechanisms of induction, and association with viral disease susceptibility","volume":"53","author":"Hale","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tmaid.2024.102697_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmaid.2024.102697_bib55","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/v15051215","article-title":"Autoantibodies to interferons in infectious diseases","volume":"15","author":"Quiros-Roldan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tmaid.2024.102697_bib56","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.vaccine.2021.01.023","article-title":"Immunogenicity after pre- and post-exposure rabies vaccination: a systematic review and dose-response meta-analysis","volume":"39","author":"Xu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib57","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/s41598-022-10281-1","article-title":"Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters","volume":"12","author":"Bernard","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmaid.2024.102697_bib58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102697_bib59","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.4161\/21645515.2014.979621","article-title":"Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG","volume":"10","author":"Peng","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2024.102697_bib60","first-page":"79","article-title":"Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate\/chromatography purified","volume":"10","author":"Hanna","year":"2018","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2024.102697_bib61","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.38.2000018","article-title":"Dutch advisory committee on rabies. Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in The Netherlands in 2018: cost and volume savings","volume":"25","author":"Schreuder","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2024.102697_bib62","series-title":"Statements Ethical statement: this study was conducted in full accordance all applicable Pasteur Institute Novi Sad Research Policies and Serbian state laws and regulations, including the Patient Rights Law","year":"2023"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:10:32Z","timestamp":1761487832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893924000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":62,"alternative-id":["S1477893924000115"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102697","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence of rabies post-exposure prophylaxis in Serbia: Nation-wide observational study (2017\u20132019)","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102697"}}